Tracy Rossin is Kyverna Therapeutic’s Senior Vice President of Corporate Affairs, Communications and Investor Relations and is responsible for leading external and internal communications, investor relations, and patient advocacy.

Tracy brings more than 20 years of strategic communications experience to Kyverna, having most recently served as the Head of Public Affairs at Kite Pharma, a global cell therapy leader, where she was responsible for leading corporate communications, product communications, employee communications, and patient advocacy. Prior to this role, she served as Vice President, Global Head of Communications at Innate Pharma, an oncology-focused biotech company, where she led both corporate and financial communications. Tracy also spent more than 12 years at AstraZeneca/MedImmune, where she held multiple U.S. and global communications roles for key therapeutic areas across AstraZeneca’s portfolio before serving as the Head of Corporate Affairs at MedImmune, the global biologics research and development arm of AstraZeneca. Before joining AstraZeneca, she held various positions at global public relations agencies working with corporate and healthcare related clients.

Tracy received a bachelor’s degree in political science and speech communication with a concentration in public relations from Miami University in Oxford, Ohio.